Biosphere, an Oakland, CA-based startup developing advanced bioproduction systems, raised $8.8M in Seed funding.
The round was led by Lowercarbon Capital and VXI Capital, with participation from Founders Fund, GS Futures, Caffeinated Capital, and B37 Ventures.
The company intends to use the funds to accelerate its engineering and scale-up efforts, enabling rapid deployment of their reactors at scale.
Led by CEO Brian Heligman, Biosphere is advancing a proprietary UV sterilization approach that paves the way for a new generation of bioreactors that are more cost-effective, and high-performing. This advance will reduce the risks associated with new product launches and drive down manufacturing costs, enabling more accessible and scalable biotechnology solutions.
The company has also secured a $1.5M contract with the U.S. Department of Defense to apply its technology toward the efficient production of critical bioproducts.
FinSMEs
09/01/2025